Varicose Vein Treatment Market is expected to reach US$ XX Mn by 2026 at a CAGR of XX% during the forecast period. A varicose vein that has enlarged and twisted, often appearing as a bulging, blue blood vessel that is the visible through the skin. Varicose veins are most common in older adults, particularly women, and occur the on the legs. Reduced trauma, greater exposure to the site of application, high operative success rates, and faster blood flow restoration, improving patient compliance & reliability, growing healthcare expenditure, and rapid growth in aging population would create commercial market opportunities. Furthermore, high cost of varicose vein treatment procedures, lack of training for vascular surgeons, implementation of health care reforms, immensely competitive market leading to difficulty in maintaining sustainability, and inconsistent reimbursement scenario are the major hindrances in the way of the varicose vein treatment market growth. Varicose Vein Treatment market is segmented by treatment mode, product, and region. Among treatment modes Endovenous Ablation is expected to grow at the fastest rate owing to progressive syndromes including chronic the insufficiency. This technology would continue to dominate the market during forecast period , to most frequently used technique. Among regions, the North America region is expected to grow at the highest CAGR during the forecast period due to the increasing incidence of varicose vein cases, high disposable income, advanced healthcare infrastructure, increasing disorders and an upward trend in the adoption of unhealthy lifestyles. The APAC region is expected to grow at the highest CAGR during the forecast period due to improving healthcare infrastructure, increasing patient awareness, rising disposable income, and benefits of early treatments for varicose vein cases. The high percentage of elderly population in developing countries such as China and Japan are increasing the incidence of major types of varicose vein in the Asia Pacific region. Rising per capita income, rapid urbanization, and expansion of advanced healthcare facilities in developing economies are likely to offer profitable opportunities to vendors in Varicose Vein Treatment market. The key players of the Varicose Vein Treatment market include Medtronic plc (Ireland), AngioDynamics, Inc. (U.S.), and biolitec AG (Austria), Syneron Medical Ltd. (Israel); Lumenis Ltd. (Israel); Dornier MedTech GmbH (Germany); Energist Group (U.K.); Eufoton s.r.l. (Italy); Vascular Solutions, Inc. (U.S.); Quanta System S.p.A. (Italy); Sciton, Inc. (U.S.); Fotona d.o.o. (Slovenia); BTG plc (U.K.); and Merz Aesthetics (U.S.) In the Varicose Vein Treatment market, Medtronic plc hold the leadership position due to production capacity expansion, brand portfolio expansion, mergers, collaborations and acquisitions. Over the past three years, the company has adopted new product launches, product enhancements, and geographic expansion as its crucial business plans to certify its dominance in this market.
Scope of the Varicose Vein Treatment report:
• Varicose Vein Treatment Market, by Treatment Mode• Endovenous Ablation • Injection Sclerotherapy • Surgical Ligation/Stripping
• Varicose Vein Treatment Market, by Products• Ablation Devices • Radiofrequency Ablation Devices • Laser Ablation Devices • Venous Closure Products
• Varicose Vein Treatment Market by region• North America • Europe • APAC • Latin America • MEA
Varicose Vein Treatment Market Key Players• Medtronic plc • Angiodynamics, Inc. • Koninklijke Philips N.V • Spectranetics, Boston Scientific Corporation • Galil Medical, Inc. • EDAP TMS S.A. • Healthtronics, Inc. • Medtronic, Plc • Mermaid Medical, Inc. • Mesonix, Inc. • Neuwave Medical, Inc. • Sonacare Medical, LLC (U.S.) Ophthalmology PACS Market